Related Experiment Videos
HCV infection in HBsAg positive chronic liver disease
F Fatuzzo1, M T Mughini, B Cacopardo
1Institute of Infectious Disease University of Catania, Italy.
Insights
Hepatitis C virus (HCV) may cause severe liver damage in patients who are also positive for Hepatitis B surface antigen (HBsAg) but show no signs of HBV replication. This suggests HCV can be a primary driver of liver disease in specific HBsAg-positive individuals.
Area of Science:
- Hepatology
- Virology
- Immunology
Background:
- Chronic liver disease affects numerous individuals globally.
- Hepatitis B virus (HBV) and Hepatitis C virus (HCV) are major causes of liver disease.
- Coinfection with HBV and HCV presents complex clinical challenges.
Purpose of the Study:
- To investigate the role of HCV in liver disease among HBsAg-positive patients.
- To determine the prevalence of anti-HCV antibodies in patients with chronic liver disease.
- To assess the correlation between HCV infection and disease severity in HBsAg-positive individuals without HBV replication.
Main Methods:
- Serological testing for anti-HCV antibodies.
- Assessment of HBV replication markers (e.g., HBsAg).
- Clinical evaluation of liver disease severity in 68 patients.
Main Results:
- Prevalence of anti-HCV antibodies was determined in the patient cohort.
- Patients positive for anti-HCV antibodies and negative for HBV replication exhibited severe liver disease.
- A significant association was observed between HCV and severe liver pathology in HBsAg-positive subjects without HBV replication.
Conclusions:
- HCV infection may be a significant contributor to severe liver damage in HBsAg-positive individuals lacking HBV replication.
- HCV should be considered in the etiological diagnosis of liver disease, even in the presence of HBsAg.
- Further research is warranted to elucidate the mechanisms of HCV-induced liver injury in this context.
Abstract:
The prevalence of anti-HCV antibodies was determined for a group of 68 patients with various forms of chronic liver disease. All patients that were anti-HCV positive but did not show signs of HBV replication had severe liver disease. We therefore suggest that HCV may be responsible for liver damage in HBsAg positive subjects when there are no evident signs of HBV replication.